These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8639376)

  • 1. Antibody catalysis via strategic use of haptenic charge.
    Kikuchi K; Hilvert D
    Acta Chem Scand (Cph); 1996 Apr; 50(4):333-6. PubMed ID: 8639376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
    Thorn SN; Daniels RG; Auditor MT; Hilvert D
    Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The scope of antibody catalysis.
    Jacobsen JR; Schultz PG
    Curr Opin Struct Biol; 1995 Dec; 5(6):818-24. PubMed ID: 8749371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural evidence for a programmed general base in the active site of a catalytic antibody.
    Golinelli-Pimpaneau B; Goncalves O; Dintinger T; Blanchard D; Knossow M; Tellier C
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9892-5. PubMed ID: 10963661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and syntheses of three haptens to generate catalytic antibodies that cleave amide bonds with nucleophilic catalysis.
    Ersoy O; Fleck R; Blanco MJ; Masamune S
    Bioorg Med Chem; 1999 Feb; 7(2):279-86. PubMed ID: 10218819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical analysis of antibody catalysis.
    Hilvert D
    Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward bifunctional antibody catalysis.
    Kikuchi K; Hannak RB; Guo MJ; Kirby AJ; Hilvert D
    Bioorg Med Chem; 2006 Sep; 14(18):6189-96. PubMed ID: 16782349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of the hapten for the induction of antibodies catalyzing aldol reaction.
    Teraishi K; Saito M; Fujii I; Nakamura H
    J Mol Graph; 1994 Dec; 12(4):282-5, 292. PubMed ID: 7696219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of shape complementarity and catalytic efficiency from a primordial antibody template.
    Xu J; Deng Q; Chen J; Houk KN; Bartek J; Hilvert D; Wilson IA
    Science; 1999 Dec; 286(5448):2345-8. PubMed ID: 10600746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic antibodies: hapten design strategies and screening methods.
    Xu Y; Yamamoto N; Janda KD
    Bioorg Med Chem; 2004 Oct; 12(20):5247-68. PubMed ID: 15388154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward the antibody-catalyzed chemiluminescence. Design and synthesis of hapten.
    Sawa M; Imaeda Y; Hiratake J; Fujii R; Umeshita R; Watanabe M; Kondo H; Oda J
    Bioorg Med Chem Lett; 1998 Mar; 8(6):647-52. PubMed ID: 9871576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-Directed Chemical Mutations on Abzymes: Large Rate Accelerations in the Catalysis by Exchanging the Functionalized Small Nonprotein Components.
    Ishikawa F; Shirahashi M; Hayakawa H; Yamaguchi A; Hirokawa T; Tsumuraya T; Fujii I
    ACS Chem Biol; 2016 Oct; 11(10):2803-2811. PubMed ID: 27552288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for a disfavored elimination reaction in catalytic antibody 1D4.
    Larsen NA; Heine A; Crane L; Cravatt BF; Lerner RA; Wilson IA
    J Mol Biol; 2001 Nov; 314(1):93-102. PubMed ID: 11724535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart.
    Haynes MR; Stura EA; Hilvert D; Wilson IA
    Science; 1994 Feb; 263(5147):646-52. PubMed ID: 8303271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The generation of antibody combining sites containing catalytic residues.
    Shokat KM; Schultz PG
    Ciba Found Symp; 1991; 159():118-28; discussion 128-34. PubMed ID: 1959444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL; Helms ED; Iverson BL
    Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.